Bruce S. Pyenson, FSA, MAAA

Authored Items
Concerns Related to Benefits and Harms of Real-World Shared Decision-Making for Lung Cancer Screening
James L. Mulshine, MD, David F. Yankelevitz, MD, Bruce S. Pyenson, FSA, MAAA
Web Exclusives in Perspectives
Are Nursing Homes COVID-19’s “Contaminated Wells,” and Will They Receive Additional Resources?
Bruce S. Pyenson, FSA, MAAA, David C. Grabowski, PhD
September 2020 Vol 13, No 4 in COVID-19, Perspectives
Computed Tomography Colonography Less Costly Than Colonoscopy for Colorectal Cancer Screening of Commercially Insured Patients
Tia Goss Sawhney, DrPH, FSA, MAAA, Bruce S. Pyenson, FSA, MAAA, David Rotter, PhD, Michele Berrios, Judy Yee, MD
October 2018 Vol 11, No 7 in Business, Original Research
The Prevalence and Payer Costs of Potentially Avoidable Emergent Care Visits for Suspected Amniotic Membrane Rupture in Pregnant Women
Christine Ferro, CHFP, Eliza Ng, MD, Bruce S. Pyenson, FSA, MAAA, Jocelyn Lau, MPH, Mona Kelkar, MBA, Nancy Phillips, MD, Chi-Wei Lu, PhD, Percy Yeung, PhD, Gloria Bachmann, MD
July 2018 Vol 11, No 5 in Business, Original Research
A “Gold Standard” for Population Health? Revisiting the FDA’s Relationship with the Hippocratic Oath
Gillian Woollett, MA, DPhil , Bruce S. Pyenson, FSA, MAAA
Web Exclusives in FDA Approvals, Select Drug Profiles
Newly Diagnosed Hepatitis C in the US Commercially Insured Population Before and After the 2012 Implementation of Expanded Screening Guidelines
Jack E. Fincham, PhD, RPh, Bruce S. Pyenson, FSA, MAAA, Gabriela Dieguez, FSA, MAAA, Christine Ferro, CHFP, Maushumi Mavinkurve, MPH, Yuri Sanchez Gonzalez, PhD
February 2018 Vol 11, No 1 in Clinical
Inpatient Utilization and Costs for Medicare Fee-for-Service Beneficiaries with Heart Failure
Kathryn Fitch, RN, MEd, Pamela M. Pelizzari, MPH, Bruce S. Pyenson, FSA, MAAA, Albert Tzeel, MD, MHSA, CPE, FAAPL
April 2016 Vol 9, No 2 in Business
The Cost of Unintended Pregnancies for Employer-Sponsored Health Insurance Plans
Gabriela Dieguez, FSA, MAAA, F. Randy Vogenberg, PhD, FASHP, Amy W. Law, PharmD, Richard Lynen, MD, James Trussell, PhD, Bruce S. Pyenson, FSA, MAAA
April 2015, Vol 8, No 2 in Business
Offering Lung Cancer Screening to High-Risk Medicare Beneficiaries Saves Lives and Is Cost-Effective: An Actuarial Analysis
Joseph R. Antos, PhD, Ellynne Dec, ASA, MAAA, Claudia I. Henschke, PhD, MD, David F. Yankelevitz, MD, Rowena Yip, MPH, Bruce S. Pyenson, FSA, MAAA
August 2014 Vol 7, No 5 in Regulatory
The Incidence Rate and Economic Burden of Community-Acquired Pneumonia in a Working-Age Population
Jonah Broulette, ASA, MAAA, F. Randy Vogenberg, PhD, FASHP, Holly Yu, MSPH, Kosuke Iwasaki, FIAJ, MAAA, Reiko Sato, PhD, Bruce S. Pyenson, FSA, MAAA
September/October 2013, Vol 6, No 8 in Business
The National Burden of Preventable Adverse Drug Events Associated with Inpatient Injectable Medications
Jeffrey M. Rothschild, MD, MPH, Bruce S. Pyenson, FSA, MAAA
Supplements
National Burden of Preventable Adverse Drug Events Associated with Inpatient Injectable Medications: Healthcare and Medical Professional Liability Costs
Betsy J Lahue, MPH, Jaan Sidorov, MD, MHSA, Bruce S. Pyenson, FSA, MAAA, Kosuke Iwasaki, FIAJ, MAAA, Helen Blumen, MD, MBA, Susan Forray, FCAS, MAAA, Jeffrey M. Rothschild, MD, MPH
November/December 2012 Vol 5, No 7 in Clinical
Utilization of Anticoagulation Therapy in Medicare Patients with Nonvalvular Atrial Fibrillation
Delete Delete, Jonah Broulette, Bruce S. Pyenson, FSA, MAAA, Kosuke Iwasaki, FIAJ, MAAA, Winghan Jacqueline Kwong, PharmD, PhD, Michael F. Murphy, MD, PhD
May/June 2012, Vol 5, No 3 in Business
Estimates of Commercial Population at High Risk for Cardiovascular Events: Impact of Aggressive Cholesterol Reduction
Kathryn Fitch, RN, MEd, David Williams, Sara W. Goldberg, FSA, MAAA, Kosuke Iwasaki, FIAJ, MAAA, Bruce S. Pyenson, FSA, MAAA, Andreas Kuznik, PhD, Henry A. Solomon, FACP, FACC
September/October 2009, Vol 2, No 6 in Clinical
Last modified: April 11, 2019
SUBSCRIBE
Copyright © Amplity Medical Communications. All rights reserved.